GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Junshi Biosciences Co Ltd (FRA:8SJ) » Definitions » EV-to-Revenue

Shanghai Junshi Biosciences Co (FRA:8SJ) EV-to-Revenue : 13.84 (As of Jun. 02, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai Junshi Biosciences Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shanghai Junshi Biosciences Co's enterprise value is €3,543.2 Mil. Shanghai Junshi Biosciences Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €256.0 Mil. Therefore, Shanghai Junshi Biosciences Co's EV-to-Revenue for today is 13.84.

The historical rank and industry rank for Shanghai Junshi Biosciences Co's EV-to-Revenue or its related term are showing as below:

FRA:8SJ' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.13   Med: 7.39   Max: 908.96
Current: 15.3

During the past 9 years, the highest EV-to-Revenue of Shanghai Junshi Biosciences Co was 908.96. The lowest was 4.13. And the median was 7.39.

FRA:8SJ's EV-to-Revenue is ranked worse than
64.99% of 997 companies
in the Biotechnology industry
Industry Median: 7.4 vs FRA:8SJ: 15.30

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-02), Shanghai Junshi Biosciences Co's stock price is €2.18. Shanghai Junshi Biosciences Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.26. Therefore, Shanghai Junshi Biosciences Co's PS Ratio for today is 8.42.


Shanghai Junshi Biosciences Co EV-to-Revenue Historical Data

The historical data trend for Shanghai Junshi Biosciences Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Junshi Biosciences Co EV-to-Revenue Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 24.25 10.10 26.35 10.45 5.55

Shanghai Junshi Biosciences Co Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.45 4.52 6.12 9.24 5.55

Competitive Comparison of Shanghai Junshi Biosciences Co's EV-to-Revenue

For the Biotechnology subindustry, Shanghai Junshi Biosciences Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Junshi Biosciences Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Junshi Biosciences Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shanghai Junshi Biosciences Co's EV-to-Revenue falls into.


;
;

Shanghai Junshi Biosciences Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shanghai Junshi Biosciences Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3543.216/256.011
=13.84

Shanghai Junshi Biosciences Co's current Enterprise Value is €3,543.2 Mil.
Shanghai Junshi Biosciences Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €256.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Junshi Biosciences Co  (FRA:8SJ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shanghai Junshi Biosciences Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.18/0.259
=8.42

Shanghai Junshi Biosciences Co's share price for today is €2.18.
Shanghai Junshi Biosciences Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Junshi Biosciences Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Junshi Biosciences Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Junshi Biosciences Co Business Description

Traded in Other Exchanges
Address
No. 987 Cai Lun Road, Level 4, Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly engaged in innovation-driven biopharmaceutical business. The company's main products include teriprizumab injection, Etesevimab, adalimumab injection, and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases, and infectious diseases. The group's operations are mainly located in the PRC and the United States of America.

Shanghai Junshi Biosciences Co Headlines

No Headlines